Shingo Oda

1.3k total citations
53 papers, 962 citations indexed

About

Shingo Oda is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Shingo Oda has authored 53 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmacology, 18 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Shingo Oda's work include Drug-Induced Hepatotoxicity and Protection (23 papers), Pharmacogenetics and Drug Metabolism (18 papers) and Drug Transport and Resistance Mechanisms (12 papers). Shingo Oda is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (23 papers), Pharmacogenetics and Drug Metabolism (18 papers) and Drug Transport and Resistance Mechanisms (12 papers). Shingo Oda collaborates with scholars based in Japan, United States and Finland. Shingo Oda's co-authors include Tsuyoshi Yokoi, Miki Nakajima, Tatsuki Fukami, Koichi Tsuneyama, S. Akai, Akira Nakajima, Yukiko Kato, Ryoichi Fujiwara, Akiko Matsubara and Moshe Finel and has published in prestigious journals such as Oncogene, American Journal Of Pathology and The Annual Review of Pharmacology and Toxicology.

In The Last Decade

Shingo Oda

52 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shingo Oda Japan 19 455 368 221 131 108 53 962
Hongbing Wang United States 20 655 1.4× 384 1.0× 362 1.6× 95 0.7× 58 0.5× 55 1.4k
Xinsheng Gu China 16 310 0.7× 472 1.3× 324 1.5× 183 1.4× 50 0.5× 31 1.1k
Xiaodong Ma China 19 238 0.5× 336 0.9× 263 1.2× 71 0.5× 77 0.7× 39 816
Xiaomei Fan China 19 512 1.1× 598 1.6× 249 1.1× 158 1.2× 72 0.7× 52 1.3k
Catherine Spire France 12 370 0.8× 341 0.9× 193 0.9× 91 0.7× 66 0.6× 14 850
Hai–Ling Qiao China 23 478 1.1× 320 0.9× 268 1.2× 126 1.0× 342 3.2× 71 1.3k
Jackie C. Bloomer United Kingdom 13 268 0.6× 261 0.7× 180 0.8× 75 0.6× 50 0.5× 20 751
Alison H. Harrill United States 19 444 1.0× 387 1.1× 149 0.7× 198 1.5× 43 0.4× 33 1.1k
David B. Buckley United States 17 499 1.1× 420 1.1× 397 1.8× 42 0.3× 122 1.1× 21 1.2k
Stephen Fowler Switzerland 22 560 1.2× 321 0.9× 314 1.4× 36 0.3× 75 0.7× 47 1.1k

Countries citing papers authored by Shingo Oda

Since Specialization
Citations

This map shows the geographic impact of Shingo Oda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Oda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Oda more than expected).

Fields of papers citing papers by Shingo Oda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Oda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Oda. The network helps show where Shingo Oda may publish in the future.

Co-authorship network of co-authors of Shingo Oda

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Oda. A scholar is included among the top collaborators of Shingo Oda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Oda. Shingo Oda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oda, Shingo & Tsuyoshi Yokoi. (2021). Recent progress in the use of microRNAs as biomarkers for drug-induced toxicities in contrast to traditional biomarkers: A comparative review. Drug Metabolism and Pharmacokinetics. 37. 100372–100372. 9 indexed citations
2.
Oda, Shingo, et al.. (2021). Plasma miR‐218a‐5p as a biomarker for acute cholestatic liver injury in rats and investigation of its pathophysiological roles. Journal of Applied Toxicology. 41(10). 1537–1552. 3 indexed citations
3.
Yoshida, Kosuke, Akira Yokoi, Mai Sugiyama, et al.. (2021). Expression of the chrXq27.3 miRNA cluster in recurrent ovarian clear cell carcinoma and its impact on cisplatin resistance. Oncogene. 40(7). 1255–1268. 17 indexed citations
4.
Oda, Shingo, et al.. (2020). Macrophage-derived extracellular vesicles regulate concanavalin A-induced hepatitis by suppressing macrophage cytokine production. Toxicology. 443. 152544–152544. 14 indexed citations
5.
Jia, Ru, Shingo Oda, & Tsuyoshi Yokoi. (2020). Pharmacological evidence for the involvement of ryanodine receptors in halothane-induced liver injury in mice. Toxicology. 443. 152560–152560. 2 indexed citations
6.
Oda, Shingo, Yuka Uchida, Michael D. Aleo, et al.. (2020). An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Archives of Toxicology. 95(1). 149–168. 19 indexed citations
7.
Koya, Yoshihiro, et al.. (2020). Exploration of small RNA biomarkers for testicular injury in the serum exosomes of rats. Toxicology. 440. 152490–152490. 8 indexed citations
8.
Matsubara, Akiko, Shingo Oda, Ru Jia, & Tsuyoshi Yokoi. (2019). Acute kidney injury model established by systemic glutathione depletion in mice. Journal of Applied Toxicology. 39(6). 919–930. 10 indexed citations
9.
Toyokuni, Shinya, et al.. (2019). A scrutiny of circulating microRNA biomarkers for drug-induced tubular and glomerular injury in rats. Toxicology. 415. 26–36. 13 indexed citations
10.
Jia, Ru, et al.. (2019). Establishment of a mouse model of troglitazone‐induced liver injury and analysis of its hepatotoxic mechanism. Journal of Applied Toxicology. 39(11). 1541–1556. 10 indexed citations
11.
Oda, Shingo, et al.. (2019). Establishment and characterization of a mouse model of rhabdomyolysis by coadministration of statin and fibrate. Toxicology Letters. 307. 49–58. 9 indexed citations
12.
Akai, S., Shingo Oda, & Tsuyoshi Yokoi. (2018). Strain and interindividual differences in lamotrigine‐induced liver injury in mice. Journal of Applied Toxicology. 39(3). 451–460. 3 indexed citations
13.
Matsubara, Akiko, Shingo Oda, S. Akai, Koichi Tsuneyama, & Tsuyoshi Yokoi. (2018). Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin. Toxicology Letters. 291. 184–193. 13 indexed citations
14.
Oda, Shingo, et al.. (2018). Comparative hepatic transcriptome analyses revealed possible pathogenic mechanisms of fasiglifam (TAK-875)-induced acute liver injury in mice. Chemico-Biological Interactions. 296. 185–197. 14 indexed citations
15.
Takeuchi, Masaki, Shingo Oda, Koichi Tsuneyama, & Tsuyoshi Yokoi. (2018). Comprehensive analysis of serum microRNAs in hepatic sinusoidal obstruction syndrome (SOS) in rats: implication as early phase biomarkers for SOS. Archives of Toxicology. 92(9). 2947–2962. 14 indexed citations
16.
Oda, Shingo, et al.. (2018). miRNA in Rat Liver Sinusoidal Endothelial Cells and Hepatocytes and Application to Circulating Biomarkers that Discern Pathogenesis of Liver Injuries. American Journal Of Pathology. 188(4). 916–928. 19 indexed citations
17.
Oda, Shingo, et al.. (2017). Neutrophil depletion protects against zomepirac-induced acute kidney injury in mice. Chemico-Biological Interactions. 279. 102–110. 2 indexed citations
18.
Akai, S., Shingo Oda, & Tsuyoshi Yokoi. (2017). Establishment of a novel mouse model for pioglitazone-induced skeletal muscle injury. Toxicology. 382. 1–9. 8 indexed citations
19.
20.
Oda, Shingo, Tatsuki Fukami, Tsuyoshi Yokoi, & Miki Nakajima. (2013). Epigenetic Regulation Is a Crucial Factor in the Repression of UGT1A1 Expression in the Human Kidney. Drug Metabolism and Disposition. 41(10). 1738–1743. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongbing Wang Breakdown of academic impact, for papers by Xinsheng Gu Breakdown of academic impact, for papers by Xiaodong Ma Breakdown of academic impact, for papers by Xiaomei Fan Breakdown of academic impact, for papers by Catherine Spire Breakdown of academic impact, for papers by Hai–Ling Qiao Breakdown of academic impact, for papers by Jackie C. Bloomer Breakdown of academic impact, for papers by Alison H. Harrill Breakdown of academic impact, for papers by David B. Buckley Breakdown of academic impact, for papers by Stephen Fowler
Rankless by CCL
2026